Total
0
Shares
CardieX (ASX:CDX) - CEO & Managing Director, Craig Cooper
CEO & Managing Director, Craig Cooper
Source: The Independent
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • CardieX (CDX) subsidiary ATCOR has been granted a new patent for its blood pressure measurement technologies which brings its total patents to 14
  • The patent was awarded by the U.S Patent & Trademark Office for the company’s non-invasive blood pressure measurement
  • More specifically, the patent relates to CardieX’s SphygmoCor technology, which it describes as the “global gold standard” for assessing the shape of the pulse and the stiffness of the arteries at a person’s heart
  • The patent is set to remain in force until 2038
  • CardieX shares are up 1.56 per cent following the news, trading at 6.5 cents

CardieX(CDX) subsidiary ATCOR has been granted a new patent for its blood pressure measurement technologies which brings its total patents to 14.

U.S Patent 11,006,842 titled “Non-Invasive Brachial Blood Pressure Measurement” was awarded to CardieX by the U.S Patent & Trademark Office and is set to remain in force until 2038.

According to CardieX, the patent is set to protect the company’s intellectual property in relation to the measurement of central blood pressure waveforms using a brachial blood pressure cuff via its SphygmoCor technology.

CardieX describes SphygmoCor as the “global gold standard” for assessing the shape of the pulse and the stiffness of the arteries at a person’s heart.

More broadly, the ASX-lister said it further enhances its intellectual property in this area.

In May 2020, ATCOR also lodged an additional new patent application for what is said to be a world-first wearable sensor technology method, CardieX said is incorporating into upcoming product releases.

CardieX’s shares are up 1.56 per cent following the news, trading at 6.5 cents at 12:56 pm AEST.

CDX by the numbers
More From The Market Herald
Advanced Human Imaging (ASX:AHI) - CEO, Vlado Bosanac

" Advanced Human Imaging (ASX:AHI) advances Meta-Twin for digital health assessments

Advanced Human Imaging (AHI) has announced the advancement of its Meta-Twin offering, a real-time, on-screen digital health assessment.
Advanced Human Imaging, AHI- CEO and Co-Founder Vlado Bosanac

" Advanced Human Imaging (ASX:AHI) appoints Edward F. Greissing Jr. to board

Advanced Human Imaging (AHI) has appointed Edward F. Greissing Jr. to board effective from November 30, 2021.
APM (ASX:APM) - CEO, Michael Anghie

" APM Human Services (ASX:APM) expands, acquiring Lifecare

APM Human Services International (APM) has acquired physiotherapy and home care group Lifecare for $68 million.
Resonance Health (ASX:RHT)

" Resonance Health (ASX:RHT) submits LiverSmart to FDA

Resonance Health (RHT) has submitted its LiverSmart device to the Food and Drug Administration (FDA) for US regulatory clearance.